Metabolic and Genetic Determinants of Glucose Shape After Oral Challenge in Obese Youths: A Longitudinal Study
Open Access
- 23 January 2020
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 105 (2) , 534-542
Abstract
Context The time-to-glucose-peak following the oral glucose tolerance test (OGTT) is a highly reproducible marker for diabetes risk. In obese youths, we lack evidence for the mechanisms underlying the effects of the TCF7L2 rs7903146 variant on glucose peak. Methods We analyzed the metabolic phenotype and the genotype for the TCF7L2 rs7903146 in 630 obese youths with normal (NGT) and impaired (IGT) glucose tolerance. Participants underwent a 3-hour, 9-point OGTT to estimate, using the oral minimal model, the disposition index (DI), the static (φstatic) and dynamic (φdynamic) components β-cell responsiveness and insulin sensitivity (SI). In a subgroup (n = 241) longitudinally followed for 2 years, we estimated the effect of time-to-glucose-peak on glucose tolerance change. Results Participants were grouped into early (φstatic (P < .001) in the absence of a difference in φdynamic. The prevalence of T-risk allele for TCF7L2 rs7903146 variant significantly increased in the late peak group. A lower DI was correlated with higher glucose concentration at 1 and 2 hours, whereas SI was inversely associated with 1-hour glucose. Glucose peak P = .015), with no subjects progressing to NGT or persisting IGT, in contrast to the 40% of progressor in those with late glucose peak. Conclusion The prevalence of T-risk allele for the TCF7L2 rs7903146 prevailed in the late time-to-glucose peak group, which in turn is associated with impaired β-cell responsiveness to glucose (φ), thereby predisposing to prediabetes and diabetes in obese youths.Keywords
Funding Information
- National Institutes of Health
- National Institute of Child Health and Human Development (R01-HD-40787, R01DK111038, R01-HD-28016, K24-HD-01464)
- National Center for Research Resources (UL1-RR-0249139)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-111038, R01-DK-114504-01A1)
- European Medical Information Framework (115372)
This publication has 44 references indexed in Scilit:
- Evidence for Early Defects in Insulin Sensitivity and Secretion Before the Onset of Glucose Dysregulation in Obese YouthsDiabetes, 2012
- Declining β-Cell Function Relative to Insulin Sensitivity With Escalating OGTT 2-h Glucose Concentrations in the Nondiabetic Through the Diabetic Range in Overweight YouthDiabetes Care, 2011
- One-hour plasma glucose concentration during the OGTT: what does it tell about β-cell function relative to insulin sensitivity in overweight/obese children?Pediatric Diabetes, 2011
- Harmonization of Glutamic Acid Decarboxylase and Islet Antigen-2 Autoantibody Assays for National Institute of Diabetes and Digestive and Kidney Diseases ConsortiaThe Journal of Clinical Endocrinology & Metabolism, 2010
- A model of GLP-1 action on insulin secretion in nondiabetic subjectsAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin ActionDiabetes, 2009
- Reproducibility of the Oral Glucose Tolerance Test in Overweight ChildrenThe Journal of Clinical Endocrinology & Metabolism, 2008
- Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetesJournal of Clinical Investigation, 2007
- TCF7L2Polymorphisms and Progression to Diabetes in the Diabetes Prevention ProgramNew England Journal of Medicine, 2006
- Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetesNature Genetics, 2006